CVS Health Co. (NYSE:CVS – Get Free Report) SVP James David Clark sold 7,513 shares of the company’s stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
CVS Health Trading Up 1.7 %
Shares of NYSE CVS opened at $66.34 on Monday. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a market cap of $83.64 billion, a price-to-earnings ratio of 18.12, a P/E/G ratio of 0.98 and a beta of 0.54. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The business has a fifty day simple moving average of $56.42 and a 200-day simple moving average of $56.73.
CVS Health (NYSE:CVS – Get Free Report) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Sell-side analysts predict that CVS Health Co. will post 5.89 EPS for the current year.
CVS Health Dividend Announcement
Institutional Investors Weigh In On CVS Health
Hedge funds have recently bought and sold shares of the business. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health in the 3rd quarter worth about $25,000. Ridgewood Investments LLC lifted its stake in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares in the last quarter. Stonebridge Financial Group LLC purchased a new stake in CVS Health in the 4th quarter worth about $28,000. Hopwood Financial Services Inc. purchased a new stake in CVS Health in the 4th quarter worth about $29,000. Finally, Legacy Investment Solutions LLC purchased a new stake in CVS Health in the 3rd quarter worth about $31,000. 80.66% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the company. JPMorgan Chase & Co. increased their price target on CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 18th. Leerink Partners raised CVS Health from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $55.00 to $75.00 in a research note on Thursday, February 13th. Truist Financial increased their price target on CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday, February 12th. Finally, UBS Group decreased their price target on CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a research note on Tuesday, February 11th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $69.83.
View Our Latest Stock Analysis on CVS
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- Compound Interest and Why It Matters When Investing
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- 3 Warren Buffett Stocks to Buy Now
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.